Innovation in harm reduction

18 October, 2016

Permissionless Innovation

 

Scientific research has made important breakthroughs in harm reduction in recent years. In the field of alcohol consumption, safer and healthier options are being developed, whereas in the area of nicotine delivery, e-cigarettes have been shown to significantly mitigate adverse health effects associated with smoking. However, these new, less harmful products are often subject to heavy regulation. For example, the new Tobacco Products Directive (TPD2), which came into force in May, dramatically tightens regulation of e-cigarettes. Yet, it is unclear that it will lead to improved health outcomes.

However, these new, less harmful products are often subject to heavy regulation. For example, the new Tobacco Products Directive (TPD2), which came into force in May, dramatically tightens regulation of e-cigarettes. Yet, it is unclear that it will lead to improved health outcomes.

In this regard, ‘permissionless innovation,’ meaning a general acceptance by policymakers of risk-taking as an effective way to achieve human progress, has been shown to deliver and is likely to continue to deliver the best results in harm reduction.

Download the PDF Briefing here

SEARCH

  • Reset

Browse our archives

Archives

View All Briefings

POPULAR BRIEFINGS


Subscribe to a freer Europe by signing up to our mailing list